Cipla Ltd, CIPLA:NSI financials

Health CarePharmaceuticals and Biotechnology

Price (INR)1,483.10
Today's Change22.10 / 1.51%
Shares traded150.23k
1 Year change+16.51%
Beta0.4572

Data delayed at least 15 minutes, as of Nov 22 2024 05:06 GMT.

More ▼

Add to Your Portfolio

Name

Currency

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)

Fiscal data as of Mar 31 2024	2024	2023	2022
REVENUE AND GROSS PROFIT
Total revenue	257,741	227,531	217,633
OPERATING EXPENSES
Cost of revenue total	99,572	93,142	95,608
Selling, general and admin. expenses, total	84,331	75,070	69,089
Depreciation/amortization	9,391	10,178	9,878
Unusual expense(income)	3,033	3,096	2,413
Other operating expenses, total	6,493	5,116	4,639
Total operating expense	207,150	190,470	184,306
Operating income	50,591	37,061	33,327
Other, net	333	338	610
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes	57,019	40,384	34,933
Provision for income taxes	15,466	12,029	9,338
Net income after taxes	41,553	28,355	25,595
Minority interest	(322)	(310)	(299)
Net income before extra. Items	41,216	28,019	25,168
Total extraordinary items	--	--	--
Net income	41,216	28,019	25,168
Inc.avail. to common excl. extra. Items	41,216	28,019	25,168
Inc.avail. to common incl. extra. Items	41,216	28,019	25,168
EPS RECONCILIATION
Basic/primary weighted average shares	807	807	807
Basic/primary eps excl. extra items	51	35	31
Basic/primary eps incl. extra items	51	35	31
Dilution adjustment	--	--	--
Diluted weighted average shares	807	808	807
Diluted eps excl. extra items	51	35	31
Diluted eps incl. extra items	51	35	31
COMMON STOCK DIVIDENDS
DPS - common stock primary issue	13	8.50	5.00
Gross dividend - common stock	10,496	6,861	4,035
PRO FORMA INCOME
Pro forma net income	--	--	--
Interest expense, supplemental	598	735	897
SUPPLEMENTAL INCOME
Depreciation, supplemental	7,012	7,037	6,813
Total special items	2,998	3,080	2,326
NORMALISED INCOME
Normalized income before taxes	60,017	43,463	37,259
Effect of special items on income taxes	813	917	622
Income tax excluding impact of special items	16,279	12,946	9,960
Normalized income after tax	43,738	30,517	27,299
Normalized income avail. to common	43,400	30,182	26,872
Basic normalized EPS	54	37	33
Diluted normalized EPS	54	37	33

Data Provided by LSEG

All markets data located on FT.com is subject to the FT Terms & Conditions

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Cipla Ltd

Select symbol

Cipla Ltd

ApplyActions

Your alerts

Income statement Back to Overview